French drugmaker Sanofi and its US partner Translate Bio will kick off human Phase 1/2 clinical trials for MRT5500, its messenger RNA-based vaccine candidate against SARS-CoV-2, the virus that causes
French drugmaker Sanofi and its US partner Translate Bio will kick off human Phase 1/2 clinical trials for MRT5500, its messenger RNA-based vaccine candidate against SARS-CoV-2, the virus that causes
Shares of Novavax popped almost 23% in Thursday’s extended market session after the biotech company announced that its coronavirus vaccine candidate showed to be 96.4% effective against the original COVID-19
Norsk Hydro ASA has clinched a €1.38 billion deal to sell its rolling business to private equity firm KPS Capital Partners, in a move to improve profitability. The Norwegian energy
General Motors confirmed on Thursday that the vehicle maker is weighing building a second battery cell manufacturing plant in the US with joint venture partner LG Energy Solutions. Shares declined
Wall Street’s main stock indexes plunged after Federal Reserve Chairman Jerome Powell comments failed to calm investor concern about the recent spike in longer-term US bond yields and inflation. The tech-heavy
